Psychobiotics Regulate the Anxiety Symptoms in Carriers of Allele A of IL-1β Gene: A Randomized, Placebo-Controlled Clinical Trial
Table 5
BUT, SLC-90R, and HAM-A frequencies.
BUT
SCL-90
HAM-A
Healthy
Dysmorphic symptoms
Healthy
Depressive symptoms
Healthy
Anxiety symptoms
A carrier
Total population
T0
54.55%
45.45%
68.18%
31.82%
56.76%
43.24%
T1
61.54%
38.46%
66.67%
33.33%
70.97%
29.03%
Δ%
-6.99%
1.52%
-14.21%
PCG
T0
100.00%
0.00%
100.00%
0.00%
37.50%
62.50%
T1
100.00%
0.00%
100.00%
0.00%
50.00%
50.00%
Δ%
0.00%
0.00%
-12.50%
POSG
T0
47.37%
52.63%
63.16%
36.84%
62.07%
37.93%
T1
58.33%
41.67%
63.64%
36.36%
78.26%
21.74%
Δ%
-10.96%
-0.48%
-16.19%
Noncarrier
Total population
T0
75.00%
25.00%
85.00%
15.00%
88.57%
11.43%
T1
88.89%
11.11%
87.50%
12.50%
93.10%
6.90%
Δ%
-13.89%
-2.50%
-4.53%
PCG
T0
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
T1
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
Δ%
0.00%
0.00%
0.00%
POSG
T0
70.59%
29.41%
82.35%
17.65%
86.21%
13.79%
T1
83.33%
16.67%
80.00%
20.00%
91.30%
8.70%
Δ%
-12.75%
2.35%
-5.10%
Total
Total population
T0
64.29%
35.71%
76.19%
23.81%
72.22%
27.78%
T1
64.29%
35.71%
76.19%
23.81%
81.67%
18.33%
Δ%
0.00%
0.00%
-9.44%
PCG
T0
100.00%
0.00%
100.00%
0.00%
64.29%
35.71%
T1
100.00%
0.00%
100.00%
0.00%
71.43%
28.57%
Δ%
0.00%
0.00%
-7.14%
POSG
T0
58.33%
41.67%
72.22%
27.78%
74.14%
25.86%
T1
66.67%
33.33%
68.75%
31.25%
84.78%
15.22%
Δ%
-8.33%
3.47%
-10.64%
Frequencies for positive/negative classification on depression, dysmorphic, and anxiety symptoms evaluated with Body Uneasiness Test (BUT), Symptom Checklist-Revised (SCL90R), and Hamilton Anxiety Rating Scale (HAM-A). Results are expressed as percentage. POSG: psychobiotic oral suspension group; PCG: placebo control group.
